Back
Larimar Therapeutics Vs. ACADIA Pharmaceuticals Industry Stock Comparison
Buy
66
LRMR
Larimar Therapeutics
Last Price:
7.14
Seasonality Move:
-20.55%
Sell
30
ACAD
ACADIA Pharmaceuticals
Last Price:
15.25
Seasonality Move:
7.01%
Buy
66
Larimar Therapeutics (LRMR)
is a Buy
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $7.12. The Score for LRMR is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- LRMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $15.25. The Score for ACAD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $7.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing selling pressure, which indicates risk of future bearish movement.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $15.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
LRMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 45.57 | Sell |
| Chaikin Money Flow: | -329572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.53 - 7.67) | Buy |
| Bollinger Bands (100): | (4.82 - 9.76) | Sell |
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 27.51 | Sell |
| Chaikin Money Flow: | -769952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.31 - 17.57) | Sell |
| Bollinger Bands (100): | (17.89 - 28.11) | Sell |
LRMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.75 | Sell |
| 20-day SMA: | 7.11 | Buy |
| 50-day SMA: | 7.94 | Sell |
| 200-day SMA: | 5.43 | Buy |
| 8-day EMA: | 7.56 | Sell |
| 20-day EMA: | 7.39 | Sell |
| 50-day EMA: | 7.52 | Sell |
| 200-day EMA: | 6.13 | Buy |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.63 | Sell |
| 20-day SMA: | 16.76 | Sell |
| 50-day SMA: | 18.43 | Sell |
| 200-day SMA: | 23.81 | Sell |
| 8-day EMA: | 16.33 | Sell |
| 20-day EMA: | 16.88 | Sell |
| 50-day EMA: | 18.67 | Sell |
| 200-day EMA: | 22.17 | Sell |
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.34 per share.
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.55 per share.
Larimar Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACADIA Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||